Zhang X - Search Results

1

ZX-29, a novel ALK inhibitor, induces apoptosis via ER stress in ALK rearrangement NSCLC cells and overcomes cell resistance caused by an ALK mutation.

Gou W, Li Z, Xu X, Shen J, Guo M, Zhou X, Zhang X, Wu Y, Zhai X, Zuo D. Gou W, et al. Among authors: zhang x. Biochim Biophys Acta Mol Cell Res. 2020 Jul;1867(7):118712. doi: 10.1016/j.bbamcr.2020.118712. Epub 2020 Mar 26. Biochim Biophys Acta Mol Cell Res. 2020. PMID: 32224191 Free article.

2

The novel ALK inhibitor ZX-29 induces apoptosis through inhibiting ALK and inducing ROS-mediated endoplasmic reticulum stress in Karpas299 cells.

Zhou X, Zhang X, Wu Z, Xu X, Guo M, Zhai X, Zuo D, Wu Y. Zhou X, et al. Among authors: zhang x. J Biochem Mol Toxicol. 2021 Mar;35(3):e22666. doi: 10.1002/jbt.22666. Epub 2020 Nov 2. J Biochem Mol Toxicol. 2021. PMID: 33140567

3

Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies.

Zhang X, Sun X, Li J, Zhang X, Gong T, Zhang Z. Zhang X, et al. Among authors: zhang z. Pharmazie. 2011 Jul;66(7):496-505. Pharmazie. 2011. PMID: 21812324

4

Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates.

Zhang X, Huai Y, Cai J, Song C, Zhang Y. Zhang X, et al. Among authors: zhang y. Int Immunopharmacol. 2019 Feb;67:176-185. doi: 10.1016/j.intimp.2018.12.014. Epub 2018 Dec 13. Int Immunopharmacol. 2019. PMID: 30553911

5

Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits.

Xu H, He L, Nie S, Guan J, Zhang X, Yang X, Pan W. Xu H, et al. Among authors: zhang x. J Control Release. 2009 Nov 16;140(1):61-8. doi: 10.1016/j.jconrel.2009.07.014. Epub 2009 Aug 3. J Control Release. 2009. PMID: 19651165

6

Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.

Wei W, Shi SJ, Liu J, Sun X, Ren K, Zhao D, Zhang XN, Zhang ZR, Gong T. Wei W, et al. Among authors: zhang xn, zhang zr. J Drug Target. 2010 Aug;18(7):557-66. doi: 10.3109/10611861003599461. J Drug Target. 2010. PMID: 20131981

7

Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.

Wang M, Yuan Y, Gao Y, Ma HM, Xu HT, Zhang XN, Pan WS. Wang M, et al. Drug Dev Ind Pharm. 2012 Sep;38(9):1134-41. doi: 10.3109/03639045.2011.641565. Epub 2011 Dec 19. Drug Dev Ind Pharm. 2012. PMID: 22182601

8

Development of multiple-unit colon-targeted drug delivery system by using alginate: in vitro and in vivo evaluation.

Lai H, Zhu F, Yuan W, He N, Zhang Z, Zhang X, He Q. Lai H, et al. Among authors: zhang z, zhang x. Drug Dev Ind Pharm. 2011 Nov;37(11):1347-56. doi: 10.3109/03639045.2011.575163. Epub 2011 Apr 27. Drug Dev Ind Pharm. 2011. PMID: 21524152

9

The Mode of Action of an Anti-Oligomeric Amyloid β-Protein Antibody Affects its Protective Efficacy.

Zhang Y, Huai Y, Zhang X, Song C, Cai J, Zhang Y. Zhang Y, et al. Among authors: zhang x. Neurotox Res. 2019 Feb;35(2):304-317. doi: 10.1007/s12640-018-9955-6. Epub 2018 Sep 18. Neurotox Res. 2019. PMID: 30229545

10

Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.

Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, Pan YS, Tang X. Zhuang CY, et al. Among authors: zhang xn. Int J Pharm. 2010 Jul 15;394(1-2):179-85. doi: 10.1016/j.ijpharm.2010.05.005. Epub 2010 May 13. Int J Pharm. 2010. PMID: 20471464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184,245 results

Search Page

Filters